From: Susceptible gene polymorphism in patients with three-vessel coronary artery disease
Gene | SNP | Allele model | MACCE group (n = 342) | Non-CAD group (n = 344) | P-value |
---|---|---|---|---|---|
CDKN2B-AS1 | rs1063192 A > G | DO AA/GG + GA | 223/119 | 195/149 | 0.022 |
RE GG/GA + AA | 14/328 | 15/329 | 0.862 | ||
CO GG/GA/AA | 14/105/223 | 15/134/195 | 0.066 | ||
rs10757274 A > G | DO AA/GG + GA | 74/268 | 112/232 | 0.001 | |
RE GG/GA + AA | 94/248 | 65/279 | 0.008 | ||
CO GG/GA/AA | 94/174/74 | 65/167/112 | 0.001 | ||
rs1333042 G > A | DO GG/AA+GA | 177/165 | 136/208 | 0.001 | |
RE AA/GA + GG | 23/319 | 35/309 | 0.104 | ||
CO AA/GA/GG | 23/142/177 | 35/173/136 | 0.004 | ||
rs1333049 G > C | DO GG/CC + GC | 67/275 | 105/239 | 0.001 | |
RE CC/GC + GG | 101/241 | 69/275 | 0.004 | ||
CO CC/GC/GG | 101/174/67 | 69/170/105 | 0.001 | ||
rs3217986 T > G | DO TT/GG + GT | 279/63 | 303/41 | 0.018 | |
RE GG/GT + TT | 3/339 | 0/344 | 0.082 | ||
CO GG/GT/TT | 3/60/279 | 0/41/303 | 0.023 | ||
rs4977574 A > G | DO AA/GG + GA | 73/269 | 111/233 | 0.001 | |
RE GG/GA + AA | 94/248 | 65/279 | 0.008 | ||
CO GG/GA/AA | 94/175/73 | 65/168/111 | 0.001 | ||
rs9632884 C > G | DO CC/GG + GC | 192/150 | 152/192 | 0.002 | |
RE GG/GC + CC | 26/316 | 25/319 | 0.867 | ||
CO GG/GC/CC | 26/124/192 | 25/167/152 | 0.004 | ||
ADAMTS13 | rs1055432 C > A | DO CC/AA+AC | 242/99 | 266/78 | 0.057 |
RE AA/AC + CC | 4/337 | 3/341 | 0.695 | ||
CO AA/AC/CC | 4/95/242 | 3/75/266 | 0.164 | ||
ABO | rs8176694 T > C | DO TT/CC + CT | 315/25 | 300/40 | 0.050 |
RE CC/CT + TT | 6/334 | 11/329 | 0.219 | ||
CO CC/CT/TT | 6/19/315 | 11/29/300 | 0.141 |